Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1983 1
1984 1
1990 1
1991 1
1996 1
1997 1
1999 1
2000 1
2001 1
2003 2
2006 2
2010 3
2012 1
2014 2
2015 1
2017 2
2018 1
2019 1
2021 3
2022 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Neonatal Abstinence Syndrome: Advances in Diagnosis and Treatment.
Wachman EM, Schiff DM, Silverstein M. Wachman EM, et al. JAMA. 2018 Apr 3;319(13):1362-1374. doi: 10.1001/jama.2018.2640. JAMA. 2018. PMID: 29614184 Review.
IMPORTANCE: Neonatal abstinence syndrome, which occurs as a result of in utero opioid exposure, affects between 6.0 and 20 newborns per 1000 live US births. ...Each of these trials was small (from 26 to 131 participants) and tested different therapies, limiting the …
IMPORTANCE: Neonatal abstinence syndrome, which occurs as a result of in utero opioid exposure, affects between 6.0 and 20 newborns p …
Interventions for the Treatment of Neonatal Abstinence Syndrome.
Cook CE, Fantasia HC. Cook CE, et al. Nurs Womens Health. 2019 Aug;23(4):357-365. doi: 10.1016/j.nwh.2019.05.006. Epub 2019 Jun 25. Nurs Womens Health. 2019. PMID: 31251931
The growing incidence of neonatal abstinence syndrome (NAS) among newborns is a public health crisis that is a sequela of the national opioid crisis. When fetuses are exposed to opioids in utero, whether through prescription pain medication, illicit substances, or supervis …
The growing incidence of neonatal abstinence syndrome (NAS) among newborns is a public health crisis that is a sequela of the national opioi …
Opioid Treatment for Neonatal Opioid Withdrawal Syndrome: Current Challenges and Future Approaches.
McPhail BT, Emoto C, Butler D, Fukuda T, Akinbi H, Vinks AA. McPhail BT, et al. J Clin Pharmacol. 2021 Jul;61(7):857-870. doi: 10.1002/jcph.1811. Epub 2021 Feb 1. J Clin Pharmacol. 2021. PMID: 33382111 Review.
Research suggests that buprenorphine may be the leading drug therapy used to treat NOWS when compared with morphine and methadone. ...Applying these approaches may contribute to optimizing the outcome by reducing cumulative drug exposure, mitigating adverse …
Research suggests that buprenorphine may be the leading drug therapy used to treat NOWS when compared with morphine and methad …
Neonatal Abstinence Syndrome Management: A Review of Recent Evidence.
Grossman M, Seashore C, Holmes AV. Grossman M, et al. Rev Recent Clin Trials. 2017;12(4):226-232. doi: 10.2174/1574887112666170816144818. Rev Recent Clin Trials. 2017. PMID: 28814260 Review.
BACKGROUND: The evaluation and management of infants with neonatal abstinence syndrome (NAS), the constellation of opioid withdrawal specific to newborns, have received renewed attention over the past decade during a new epidemic of opioid use, misuse, abuse, and dependenc …
BACKGROUND: The evaluation and management of infants with neonatal abstinence syndrome (NAS), the constellation of opioid withdrawal …
Contextual risk and psychosocial profiles of opioid-using mothers: A mixed-methods study.
Beltrán-Arzate K, Hodson K, Tes HK, Bowyer SH, Ratliff HC, Abraham MM, Johnson E, Harris M, Jaekel J. Beltrán-Arzate K, et al. Womens Health (Lond). 2021 Jan-Dec;17:17455065211060624. doi: 10.1177/17455065211060624. Womens Health (Lond). 2021. PMID: 34818934 Free PMC article.
A sample of 50 opioid-using biological mothers of infants diagnosed with neonatal opioid withdrawal syndrome (NOWS) were studied using a set of standardized and open-ended questions, along with medical records extraction. ...Thematic content analysis revealed four themes: …
A sample of 50 opioid-using biological mothers of infants diagnosed with neonatal opioid withdrawal syndrome (NOWS) were studied usin …
Use of buprenorphine in pregnancy: patient management and effects on the neonate.
Johnson RE, Jones HE, Fischer G. Johnson RE, et al. Drug Alcohol Depend. 2003 May 21;70(2 Suppl):S87-101. doi: 10.1016/s0376-8716(03)00062-0. Drug Alcohol Depend. 2003. PMID: 12738353 Review.
It is estimated that 55-94% of infants born to opioid-dependent mothers in US will show signs of opioid withdrawal. Buprenorphine has been reported to produce little or no autonomic signs or symptoms of opioid withdrawal following abrupt termination in adults. To da …
It is estimated that 55-94% of infants born to opioid-dependent mothers in US will show signs of opioid withdrawal. Buprenorphine has …
Treatment of neonatal abstinence syndrome.
Johnson K, Gerada C, Greenough A. Johnson K, et al. Arch Dis Child Fetal Neonatal Ed. 2003 Jan;88(1):F2-5. doi: 10.1136/fn.88.1.f2. Arch Dis Child Fetal Neonatal Ed. 2003. PMID: 12496218 Free PMC article. Review.
Neonatal abstinence syndrome (NAS) is suffered by infants withdrawing from substances on which they have become physically dependent after in utero exposure. ...Many infants with NAS have been exposed to multiple substances in utero. Further research is requi …
Neonatal abstinence syndrome (NAS) is suffered by infants withdrawing from substances on which they have become physically dependent …
A practical guide to the diagnosis and management of amenorrhoea.
Crosignani PG, Vegetti W. Crosignani PG, et al. Drugs. 1996 Nov;52(5):671-81. doi: 10.2165/00003495-199652050-00005. Drugs. 1996. PMID: 9118817 Review.
Both congenital and acquired anomalies in the structure of the uterus and vagina could produce amenorrhoea; nevertheless, in the vast majority of patients, amenorrhoea is related to an ovarian malfunction. ...Since these women have some ovarian activity, they are not hypoe …
Both congenital and acquired anomalies in the structure of the uterus and vagina could produce amenorrhoea; nevertheless, in the vast …
Pharmacologic management of the opioid neonatal abstinence syndrome.
Kraft WK, van den Anker JN. Kraft WK, et al. Pediatr Clin North Am. 2012 Oct;59(5):1147-65. doi: 10.1016/j.pcl.2012.07.006. Epub 2012 Aug 30. Pediatr Clin North Am. 2012. PMID: 23036249 Free PMC article. Review.
Opioid use in pregnant women has increased over the last decade. Following birth, infants with in utero exposure demonstrate signs and symptoms of withdrawal known as the neonatal abstinence syndrome (NAS). ...There is a general lack of high-quality clinical trial d …
Opioid use in pregnant women has increased over the last decade. Following birth, infants with in utero exposure demonstrate signs an …
Neonatal Abstinence Syndrome: Update on Diagnostic and Therapeutic Strategies.
Raffaeli G, Cavallaro G, Allegaert K, Wildschut ED, Fumagalli M, Agosti M, Tibboel D, Mosca F. Raffaeli G, et al. Pharmacotherapy. 2017 Jul;37(7):814-823. doi: 10.1002/phar.1954. Epub 2017 Jul 2. Pharmacotherapy. 2017. PMID: 28519244 Review.
Both prescription opioid use and illicit opioid abuse have increased dramatically in recent years. Prolonged in utero drug exposure may result in neonatal abstinence syndrome (NAS), an acute multisystemic clinical entity that occurs in the first days of life. ...The …
Both prescription opioid use and illicit opioid abuse have increased dramatically in recent years. Prolonged in utero drug exp …
29 results